Immutep Limited (NASDAQ:IMMP) has a beta value of 0 and has seen 1,611,596 shares traded in the last trading session. The company, currently valued at $225.95 Million, closed the last trade at $3.53 per share which meant it lost -$0.01 on the day or -0.28% during that session. The IMMP stock price is -125.21% off its 52-week high price of $7.95 and 80.74% above the 52-week low of $0.68. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.9 Million shares traded. The 3-month trading volume is 2.8 Million shares.
The consensus among analysts is that Immutep Limited (IMMP) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 5 have rated it as a Hold, with 5 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.
Immutep Limited (NASDAQ:IMMP) trade information
Despite being -0.28% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Apr 08 when the IMMP stock price touched $3.65-3 or saw a rise of 3.29%. Year-to-date, Immutep Limited shares have moved 12.42%, while the 5-day performance has seen it change 12.78%. Over the past 30 days, the shares of Immutep Limited (NASDAQ:IMMP) have changed 37.89%. Short interest in the company has seen 151.16 Million shares shorted with days to cover at 53.99.
Wall Street analysts have a consensus price target for the stock at $6.64, which means that the shares’ value could jump 88.1% from current levels. The projected low price target is $5.71 while the price target rests at a high of $8. In that case, then, we find that the current price level is +126.63% off the targeted high while a plunge would see the stock lose 61.76% from current levels.
Immutep Limited (IMMP) estimates and forecasts
2 analysts offering their estimates for the company have set an average revenue estimate of $850Million for the current quarter. 2 have an estimated revenue figure of $850Million for the next quarter concluding in March 01, 2016. Year-ago sales stood $9.92 Million and $9.92 Million respectively for this quarter and the next, and analysts expect sales will grow by -91.4% for the current quarter and -91.4% for the next.
Earnings growth for 2021 is a modest +0%.
Immutep Limited (NASDAQ:IMMP)’s Major holders
Insiders own 0% of the company shares, while shares held by institutions stand at 0.37% with a share float percentage of 0.37%. Investors are also buoyed by the number of investors in a company, with Immutep Limited having a total of 11 institutions that hold shares in the company. The top two institutional holders are Morgan Stanley with over 102.74 Thousand shares worth more than $322.59 Thousand. As of December 30, 2020, Morgan Stanley held 0.15% of shares outstanding.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The other major institutional holder is HighTower Advisors, LLC, with the holding of over 36.1 Thousand shares as of December 30, 2020. The firm’s total holdings are worth over $113.35 Thousand and represent 0.05% of shares outstanding.